General MedicationsORALStandard
HERNEXEOS
ZONGERTINIB
Standard Dose
60MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview HERNEXEOS is listed in Drugs@FDA under application 219042 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient ZONGERTINIB Form and strength TABLET;ORAL - 60MG Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2026-02-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview HERNEXEOS is listed in Drugs@FDA under application 219042 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient ZONGERTINIB Form and strength TABLET;ORAL - 60MG Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2026-02-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.